COVID-19: Mechanisms of vaccination and immunity
DE Speiser, MF Bachmann - Vaccines, 2020 - mdpi.com
Vaccines are needed to protect from SARS-CoV-2, the virus causing COVID-19. Vaccines
that induce large quantities of high affinity virus-neutralizing antibodies may optimally …
that induce large quantities of high affinity virus-neutralizing antibodies may optimally …
COVID-19: coronavirus vaccine development updates
J Zhao, S Zhao, J Ou, J Zhang, W Lan, W Guan… - Frontiers in …, 2020 - frontiersin.org
Coronavirus Disease 2019 (COVID-19) is caused by Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
Coronavirus 2 (SARS-CoV-2), a newly emerged coronavirus, and has been pandemic since …
[HTML][HTML] COVID-19 vaccines: Current evidence and considerations
A Tavilani, E Abbasi, FK Ara, A Darini, Z Asefy - Metabolism open, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic is a global crisis, with
devastating health, business and social impacts. Vaccination is a safe, simple, and effective …
devastating health, business and social impacts. Vaccination is a safe, simple, and effective …
COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
Coronavirus Disease 2019 named as COVID-19 imposing a huge burden on public health
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …
as well as global economies, is caused by a new strain of betacoronavirus named as SARS …
COVID-19 vaccines: The status and perspectives in delivery points of view
Due to the high prevalence and long incubation periods often without symptoms, the severe
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected millions of individuals …
A comprehensive review on COVID-19 vaccines: development, effectiveness, adverse effects, distribution and challenges
The present SARS-CoV-2 induced COVID-19 pandemic is responsible for millions of deaths,
illnesses, and economic loss worldwide. There are 21 COVID-19 vaccines from different …
illnesses, and economic loss worldwide. There are 21 COVID-19 vaccines from different …
Recent advances, approaches and challenges in targeting pathways for potential COVID-19 vaccines development
During the COVID-19 pandemic in a modern era, there is a global consensus on the need
for the rapid development of a vaccine against SARS-CoV-2 for effective and sustainable …
for the rapid development of a vaccine against SARS-CoV-2 for effective and sustainable …
[HTML][HTML] A Covid-19 milestone attained—a correlate of protection for vaccines
A Covid-19 Milestone Attained — A Correlate of Protection for Vaccines | New England Journal of
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
Medicine Skip to main content The New England Journal of Medicine homepage Advanced …
[HTML][HTML] Review of Covid-19 vaccine clinical trials-A puzzle with missing pieces
HF Kwok - International Journal of Biological Sciences, 2021 - ncbi.nlm.nih.gov
A year after the initial outbreak of Covid-19 pandemic, several Phase III clinical trials
investigating vaccine safety and efficacy have been published. These vaccine candidates …
investigating vaccine safety and efficacy have been published. These vaccine candidates …
Recent developments in SARS‐CoV‐2 vaccines: A systematic review of the current studies
M Sadeghalvad, AH Mansourabadi… - Reviews in Medical …, 2023 - Wiley Online Library
Designing and manufacturing efficient vaccines against coronavirus disease 2019 (COVID‐
19) is a major objective. In this systematic review, we aimed to evaluate the most important …
19) is a major objective. In this systematic review, we aimed to evaluate the most important …